Vertigo Market Size in the 7MM is Estimated to Exceed USD 2.2 Billion by 2035

How big is the vertigo market?

The vertigo market size reached a value of USD 1.5 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 2.2 Billion by 2035, exhibiting a growth rate (CAGR) of 3.87% during 2025-2035.

Vertigo is an entity that describes balance loss sensations, usually chronic or cyclical, a condition in which a person feels that his surroundings are moving whereas they are not. There are two kinds of vertigo: one is peripheral; the other is central. Yet, the most common is peripheral vertigo, an abnormal condition affecting either the vestibular nerve or the internal ear that links the inner ear with the brain.

Increased Market Growth and Incidence

The level of vertigo is notably on the rise especially in geriatrics. New cases of benign paroxysmal positional vertigo, Meniere's disease, and vestibular migraines are increasingly becoming common, adding to the already existing patient pool. Recent research suggests that around 40% of adults in the United States experience some level of vertigo during their life and women are slightly more likely to suffer from it than men. This data highlights the increasing need for effective measures for diagnostic and therapeutic solutions.

Request for a sample of this report: https://www.imarcgroup.com/vertigo-market/requestsample

Advancements in Technology for Diagnosis and Treatment

Modern technology has brought a huge difference in dealing with issues of vertigo management and diagnosis. Devices for video-nystagmography (VNG) and vestibular evoked myogenic potentials (VEMP) have developed better accuracy in precision vertigo diagnosis. These techniques enhance the ability to precisely detect and diagnose diseases of the vestibular system and disorders which aids in the identification of specific treatment plans.

Digital health solutions have emerged for consideration under treatment. To illustrate, Abbott Laboratories has released the 'Vertigo Coach' app in India, which equips users with triggers as well as symptom management techniques, thereby enhancing the experience they have during consultations with physicians. Moreover, telemedicine services coupled with remote monitoring devices are improving access to healthcare services in underserved areas with inadequate medical facilities.

Market Outlook and New Therapies

The vertigo market is gradually shifting toward more non-pharmacological options. There is a greater utilization of vestibular rehabilitation therapy (VRT), which is a type of physical therapy that uses exercises to enhance a patient's balance and reduce dizziness . Further, some patients are seeking more known research herbs and alternative therapies like Ginkgo biloba and ginger root, broadening the scope of available treatment strategies to help alleviate symptoms .

The management of vertigo is no longer restricted for wearable technology. Body motion, balance, and walking pattern trackers provide patients and healthcare professionals with real-time updates that enable the formulation of individualized treatment plans, thereby enhancing patient outcomes.

Ask the Analyst for Customization and Get Full Insights with TOC: https://www.imarcgroup.com/request?type=report&id=6726&flag=E

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the vertigo market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the vertigo market
Reimbursement scenario in the market
In-market and pipeline drugs

This report also provides a detailed analysis of the current vertigo marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

IMARC Group Offers Other Reports:

Retinitis Pigmentosa Market https://www.imarcgroup.com/retinitis-pigmentosa-market

Age-related macular degeneration market https://www.imarcgroup.com/age-related-macular-degeneration-market

Lambert-Eaton Myasthenic Syndrome Market https://www.imarcgroup.com/lambert-eaton-myasthenic-syndrome-market

Chiari Malformation Market https://www.imarcgroup.com/chiari-malformation-market

Kawasaki Disease Market https://www.imarcgroup.com/kawasaki-disease-market

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.